home / stock / rvv:cc / rvv:cc news


RVV:CC News and Press, Revive Therapeutics Ltd - Ordinary Shares From 12/08/23

Stock Information

Company Name: Revive Therapeutics Ltd - Ordinary Shares
Stock Symbol: RVV:CC
Market: CNQC
Website: revivethera.com

Menu

RVV:CC RVV:CC Quote RVV:CC Short RVV:CC News RVV:CC Articles RVV:CC Message Board
Get RVV:CC Alerts

News, Short Squeeze, Breakout and More Instantly...

RVV:CC - Expected Canadian Company Earnings on Friday, December 8th, 2023

Canadian Western Bank (CWB:CA) is expected to report $0.89 for Q4 2023 Verisante Technology Inc. (VER.H:CA) is expected to report for Q1 2024 Imperial Ginseng Products Ltd. (IGP:CA) is expected to report for quarter end 2023-09-30 Western Alaska Minerals Corp. (WAM:CA) is expected to ...

RVV:CC - Expected Canadian Company Earnings on Friday, December 1st, 2023

Novo Resources Corp. (NVO:CA) is expected to report for quarter end 2023-09-30 Horizons Gold ETF (HUG:CA) is expected to report for quarter end 2023-09-30 Canadian Western Bank (CWB:CA) is expected to report $0.89 for Q4 2023 FSD Pharma Inc Subordinate Voting Shares (HUGE:CNX) is expe...

RVV:CC - Expected Canadian Company Earnings on Friday, November 24th, 2023

Spanish Mountain Gold Ltd. (SPA:CA) is expected to report for Q3 2023 Desert Mountain Energy Corp. (DME:CA) is expected to report for Q3 2023 Armor Minerals Inc. (A.H:CA) is expected to report for quarter end 2023-09-30 Three Valley Copper Corp. (TVC.H:CA) is expected to report for Q2...

RVV:CC - Revive Therapeutics Enters into Agreement with Defence Research and Development Canada for Evaluating Bucillamine for Nerve Agent Exposure

TORONTO, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, to...

RVV:CC - Revive Therapeutics Provides Update of Novel Bucillamine Formulation Development

TORONTO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, pr...

RVV:CC - Expected Canadian Company Earnings on Tuesday, September 26th, 2023

Solaris Resources Inc. (SLS:CA) is expected to report for Q2 2023 CGX Energy Inc. (OYL:CA) is expected to report for Q1 2024 Edgewater Exploration Ltd. (EDW.H:CA) is expected to report for Q2 2023 CVR Medical Corp (CVM.H:CA) is expected to report for quarter end 2023-06-30 Tower R...

RVV:CC - Expected Canadian Company Earnings on Tuesday, September 19th, 2023

Amex Exploration Inc. (AMX:CA) is expected to report for Q2 2023 NioCorp Developments Ltd. (NB:CA) is expected to report for Q4 2023 Western Alaska Minerals Corp. (WAM:CA) is expected to report $-0.03 for Q2 2023 Solaris Resources Inc. (SLS:CA) is expected to report for Q2 2023 De...

RVV:CC - Expected Canadian Company Earnings on Tuesday, September 12th, 2023

Aberdeen International Inc. (AAB:CA) is expected to report for Q1 2024 Mainstreet Equity Corp. (MEQ:CA) is expected to report for Q3 2023 WildBrain Ltd. Common and Variable Voting Shares (WILD:CA) is expected to report for Q4 2023 Amex Exploration Inc. (AMX:CA) is expected to report f...

RVV:CC - Expected Canadian Company Earnings on Tuesday, September 5th, 2023

Kure Technologies Inc. (KUR.H:CA) is expected to report for Q2 2023 Delivra Health Brands Inc. (DHB:CA) is expected to report for Q1 2024 FuelPositive Corporation (NHHH:CA) is expected to report for Q3 2023 Baru Gold Corp. (BARU:CA) is expected to report for quarter end 2023-05-31 ...

RVV:CC - Expected earnings - Revive Therapeutics Ltd - Ordinary Shares

Revive Therapeutics Ltd - Ordinary Shares (RVV:CNX) is expected to report for quarter end 2023-06-30

Previous 10 Next 10